Genetic Variation of Omi/HtrA2 and Parkinson's Disease

Parkinsonism and Related Disorders - Netherlands
doi 10.1016/j.parkreldis.2008.08.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Binding Specificity and Regulation of the Serine Protease and PDZ Domains of HtrA2/Omi

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

Characterization of a Novel and Specific Inhibitor for the Pro-Apoptotic Protease Omi/HtrA2

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

Omi/HtrA2 Protease Associated Cell Apoptosis Participates in Blood-Brain Barrier Dysfunction

Frontiers in Molecular Neuroscience
Molecular NeuroscienceMolecular BiologyCellular
2019English

Genetic Modifiers of Neurodegeneration in aDrosophilaModel of Parkinson's Disease

Genetics
Genetics
2018English

Mitochondrial Dysfunction in Genetic Animal Models of Parkinson's Disease

Antioxidants and Redox Signaling
Cell BiologyMolecular BiologyBiochemistryClinical BiochemistryMedicinePhysiology
2012English

Enhanced HtrA2/Omi Expression in Oxidative Injury to Retinal Pigment Epithelial Cells and Murine Models of Neurodegeneration

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2009English

Intramitochondrial Serine Protease Activity of Omi/HtrA2 Is Required for Caspase-Independent Cell Death of Human Neutrophils

Cell Death and Differentiation
Cell BiologyMolecular Biology
2004English

Autocatalytic Processing of HtrA2/Omi Is Essential for Induction of Caspase-Dependent Cell Death Through Antagonizing XIAP

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

Pharmacogenetics of Cardiovascular Disease: Genetic Variation and Statin Intolerance

2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy